Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
0078
Strengths (from the 100 most recently listed products)
Valsartan 160 mg/1; Amlodipine besylate 5 mg/1; Ribociclib succinate 200 mg/1; Hydrochlorothiazide 25 mg/1; Amlodipine besylate 10 mg/1; Alpelisib 50 mg/1; Eltrombopag olamine 12.5 mg/1; Eltrombopag olamine 25 mg/1; Deferasirox 90 mg/1; Deferasirox 180 mg/1; Deferasirox 360 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Imatinib mesylate 400 mg/1; Everolimus 5 mg/1; Hydrochlorothiazide 12.5 mg/1; Valsartan 320 mg/1; Remibrutinib 25 mg/1
Dosage forms
Tablet, Film coated, Tablet, Capsule, Kit, Injection, Solution, Granule, Tablet, For suspension, Injection, Injection, Suspension, Patch, Extended release, Pellet, Injection, Powder, Lyophilized, For solution, Powder, For suspension, Injection, Solution, Concentrate, Powder, For solution, Capsule, Liquid filled, Solution/ drops, Suspension/ drops
Routes
Oral, Intravenous, Subcutaneous, Ophthalmic, Transdermal, Intravitreal
Drug classes (FDA established)
Kinase Inhibitor, Angiotensin 2 Receptor Blocker, mTOR Inhibitor Immunosuppressant, Neprilysin Inhibitor, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Thrombopoietin Receptor Agonist, Iron Chelator, Sphingosine 1-phosphate Receptor Modulator, Thiazide Diuretic, Interleukin-17A Antagonist, Cholinesterase Inhibitor, CD19-directed Chimeric Antigen Receptor, Genetically-modified Autologous T Cells, Antimalarial, Endothelin Receptor Antagonist, Corticosteroid, Complement Factor B Inhibitor, Radioligand Therapeutic Agent, Selectin Blocker, Anthelmintic, Topoisomerase Inhibitor, Lymphocyte Function-Associated Antigen-1 Antagonist, Nonsteroidal Anti-inflammatory Drug, CD20-directed Cytolytic Antibody
HCPCS / J-code
None in Med-Code's directory for these products
Package NDCs
135 (from the 100 most recently listed products)

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Novartis Pharmaceuticals Corporation NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
RhapsidoremibrutinibRemibrutinib 25 mg/1TabletOral0078-148300078-1483-2000078-1483-9200078-1483-93—
VanrafiaatrasentanAtrasentan hydrochloride .75 mg/1Tablet, Film coatedOral0078-142000078-1420-15—
Triesencetriamcinolone acetonideTriamcinolone acetonide 40 mg/mLInjection, SuspensionOphthalmic0078-089700078-0897-78—
VijoicealpelisibAlpelisib 50 mg/1GranuleOral0078-117500078-1175-51—
Entrestosacubitril and valsartanSacubitril 6 mg/1; Valsartan 6 mg/1PelletOral0078-123100078-1231-20—
Entrestosacubitril and valsartanSacubitril 15 mg/1; Valsartan 16 mg/1PelletOral0078-123800078-1238-20—
FabhaltaiptacopanIptacopan hydrochloride 200 mg/1CapsuleOral0078-118900078-1189-20—
CosentyxsecukinumabSecukinumab 25 mg/mLInjection, Solution, ConcentrateIntravenous0078-116800078-1168-61—
TafinlardabrafenibDabrafenib mesylate 10 mg/1Tablet, For suspensionOral0078-115400078-1154-21—
MekinisttrametinibTrametinib dimethyl sulfoxide .05 mg/mLPowder, For solutionOral0078-116100078-1161-47—
VijoicealpelisibAlpelisib 50 mg/1TabletOral0078-102100078-1021-8400078-1021-91—
VijoicealpelisibAlpelisib 125 mg/1TabletOral0078-102800078-1028-8400078-1028-91—
Vijoicealpelisib—Kit0078-103500078-1035-0200078-1035-92—
Locametzkit for the preparation of gallium ga 68 gozetotideGozetotide 25 ug/1Injection, Powder, Lyophilized, For solutionIntravenous0078-122400078-1224-61—
Pluvictolutetium lu 177 vipivotide tetraxetanLutetium lu-177 vipivotide tetraxetan 27 mCi/mLInjection, SolutionIntravenous0078-121700078-1217-61—
LeqvioinclisiranInclisiran sodium 284 mg/1.5mLInjection, SolutionSubcutaneous0078-100000078-1000-6000078-1000-98—
ScemblixasciminibAsciminib hydrochloride 20 mg/1Tablet, Film coatedOral0078-109100078-1091-2000078-1091-94—
ScemblixasciminibAsciminib hydrochloride 40 mg/1Tablet, Film coatedOral0078-109800078-1098-2000078-1098-94—
ScemblixasciminibAsciminib hydrochloride 100 mg/1Tablet, Film coatedOral0078-119600078-1196-20—
TabrectacapmatinibCapmatinib hydrochloride 150 mg/1Tablet, Film coatedOral0078-070900078-0709-5600078-0709-94—
TabrectacapmatinibCapmatinib hydrochloride 200 mg/1Tablet, Film coatedOral0078-071600078-0716-5600078-0716-94—
AdakveocrizanlizumabCrizanlizumab 10 mg/mLInjectionIntravenous0078-088300078-0883-61—
BeovubrolucizumabBrolucizumab 6 mg/.05mLInjection, SolutionIntravitreal0078-082700078-0827-6000078-0827-98—
PiqrayalpelisibAlpelisib 200 mg/1TabletOral0078-070100078-0701-84—
PiqrayalpelisibAlpelisib 150 mg/1TabletOral0078-070800078-0708-0200078-0708-91—
Piqrayalpelisib—Kit0078-071500078-0715-0200078-0715-91—
MayzentsiponimodSiponimod .25 mg/1Tablet, Film coatedOral0078-097900078-0979-1200078-0979-5000078-0979-89+1 more—
MayzentsiponimodSiponimod 2 mg/1Tablet, Film coatedOral0078-098600078-0986-1500078-0986-4500078-0986-93+1 more—
MayzentsiponimodSiponimod 1 mg/1Tablet, Film coatedOral0078-101400078-1014-1500078-1014-93—
ZykadiaceritinibCeritinib 150 mg/1Tablet, Film coatedOral0078-069400078-0694-4800078-0694-84—
EgatentriclabendazoleTriclabendazole 250 mg/1TabletOral0078-093700078-0937-91—
Promactaeltrombopag olamineEltrombopag olamine 12.5 mg/1Powder, For suspensionOral0078-097200078-0972-61—
Promactaeltrombopag olamineEltrombopag olamine 25 mg/1Powder, For suspensionOral0078-069700078-0697-61—
KymriahtisagenlecleucelTisagenlecleucel 60000000 1/1Injection, SuspensionIntravenous0078-095800078-0958-19—
KymriahtisagenlecleucelTisagenlecleucel 2000000 1/1Injection, SuspensionIntravenous0078-084600078-0846-19—
JadenudeferasiroxDeferasirox 90 mg/1GranuleOral0078-072700078-0727-15—
JadenudeferasiroxDeferasirox 180 mg/1GranuleOral0078-071300078-0713-15—
JadenudeferasiroxDeferasirox 360 mg/1GranuleOral0078-072000078-0720-15—
RydaptMidostaurin 25 mg/1Capsule, Liquid filledOral0078-069800078-0698-1900078-0698-99—
KisqaliribociclibRibociclib succinate 200 mg/1Tablet, Film coatedOral0078-086000078-0860-01—
KisqaliribociclibRibociclib succinate 200 mg/1Tablet, Film coatedOral0078-086700078-0867-42—
KisqaliribociclibRibociclib succinate 200 mg/1Tablet, Film coatedOral0078-087400078-0874-63—
IlariscanakinumabCanakinumab 150 mg/mLInjection, SolutionSubcutaneous0078-073400078-0734-61—
Hycamtintopotecan hydrochlorideTopotecan hydrochloride 4 mg/4mLInjection, Powder, Lyophilized, For solutionIntravenous0078-067400078-0674-61—
Promactaeltrombopag olamineEltrombopag olamine 12.5 mg/1Tablet, Film coatedOral0078-068400078-0684-15—
TykerblapatinibLapatinib ditosylate 250 mg/1TabletOral0078-067100078-0671-19—
Sandostatin LAR Depotoctreotide acetate—Kit0078-081100078-0811-81—
Sandostatin LAR Depotoctreotide acetate—Kit0078-081800078-0818-81—
Sandostatin LAR Depotoctreotide acetate—Kit0078-082500078-0825-81—
Votrientpazopanib hydrochloridePazopanib hydrochloride 200 mg/1Tablet, Film coatedOral0078-107700078-1077-66—

Novartis Pharmaceuticals Corporation: common questions

What is Novartis Pharmaceuticals Corporation's NDC labeler code?
0078. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Novartis Pharmaceuticals Corporation?
Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in